Karanth et al. (28) supported that quadruple misfolded proteins are a common substrate for cognitive impairment and the prevalence of comorbid α-synuclein and TDP-43 with AD pathology (tau and Aβ) complicate efforts to identify therapies to treat and prevent AD. The gene discussed is MAPT; the disease is Alzheimer disease.